Design characteristics, risk of bias, and reporting of randomised controlled trials supporting approvals of cancer drugs by European Medicines Agency, 2014-16: cross sectional analysis

18 September 2019 - In this study, the investigators examined the characteristics of randomised controlled trials that supported approval of cancer ...

Read more →

Taranaki man fearful drug funding change will bring back a life of seizures

13 September 2019 - For three years now a normal life has cost Nick Coulton $10 every three months. From ...

Read more →

China’s grip on pharmaceutical drugs is a national security issue

10 September 2019 - If you take a pill every day to treat high blood pressure or high cholesterol, you ...

Read more →

Batten disease treatment: parents win battle ahead of court date

11 September 2019 - Families of children with a rare degenerative disease have won their fight for funding for NHS ...

Read more →

Draft Pelosi plan targets drugs lacking biosimilar or generic option

12 September 2019 - While chances of her leaked plan to force lower drug prices in the United States getting through ...

Read more →

In U.S. biosimilars run into more roadblocks

12 September 2019 - In a recent op-ed in the Wall Street Journal Peter Bach asks whether it's time to ...

Read more →

Public plans covered only 26% of the 491 new drugs approved by Health Canada from 2009 to 2018; national pharmacare is an empty promise for 23.2 million Canadians now covered by private plans

11 September 2019 - Two new studies confirm the abysmal state of access to innovative medicines in Canada’s publicly funded drug ...

Read more →

Why Canada can't be America's pharmacy

11 September 2019 - Canada doesn't have enough drugs to share, and it doesn't want that role. ...

Read more →

New rules will keep the best medications from desperate Canadians

12 September 2019 - One reaction to recent amendments to the rules of the federal Patented Medicine Prices Review Board, ...

Read more →

Big Pharma is abusing patents, and it's hurting Americans

12 September 2019 - The American patent system has, since our nation's founding, served as a cornerstone of innovation. But ...

Read more →

Ardelyx receives FDA approval for Ibsrela (tenapanor), an NHE3 sodium transport inhibitor, for the treatment of irritable bowel syndrome with constipation

12 September 2019 - Approval supported by two Phase 3 trials demonstrating a statistically significant reduction in constipation and abdominal pain ...

Read more →

Nucala is the first biologic approved in the US for six to 11-year-old children with severe eosinophilic asthma

12 September 2019 - GlaxoSmithKline today announced that the US FDA has approved Nucala (mepolizumab) for use in children as young ...

Read more →

Aspen's drug to prevent preterm birth approved by FDA

13 September 2019 - The U.S. Food and Drug Administration (FDA) has approved Aspen Pharmacare’s hydroxyprogesterone caproate, which is used to ...

Read more →

ICER publishes evidence report on additive cardiovascular disease therapies

12 September 2019 - Pricing of rivaroxaban and icosapent ethyl aligns well with treatments’ benefits for patients; expert roundtable will discuss ...

Read more →

SMC U-turn for Vertex’s CF drugs

12 September 2019 - Vertex has announced that following a change of heart by the SMC, eligible cystic fibrosis patients ...

Read more →

Be grateful for your health insurance company

11 September 2019 - It has the thankless job of saying ‘no.’ But policing claims allows you to get better benefits. ...

Read more →